Somerville Kurt F Makes New Investment in Danaher Corporation $DHR

Somerville Kurt F bought a new stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 45,245 shares of the conglomerate’s stock, valued at approximately $8,618,000. Danaher accounts for about 2.1% of Somerville Kurt F’s investment portfolio, making the stock its 19th largest position.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Main Street Group LTD bought a new stake in Danaher during the first quarter valued at about $25,000. N.E.W. Advisory Services LLC purchased a new stake in shares of Danaher during the second quarter valued at about $25,000. JPL Wealth Management LLC purchased a new stake in shares of Danaher during the third quarter valued at about $25,000. WFA of San Diego LLC bought a new stake in shares of Danaher in the 2nd quarter valued at about $26,000. Finally, Hilton Head Capital Partners LLC purchased a new position in shares of Danaher in the 4th quarter worth approximately $27,000. Institutional investors own 79.05% of the company’s stock.

Danaher Price Performance

Shares of NYSE DHR opened at $216.14 on Friday. The stock has a market capitalization of $151.94 billion, a price-to-earnings ratio of 38.39, a PEG ratio of 2.63 and a beta of 0.78. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The firm’s 50 day simple moving average is $195.01 and its 200-day simple moving average is $192.43. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.77 EPS. Analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Analysts Set New Price Targets

Several brokerages recently weighed in on DHR. HSBC dropped their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Argus decreased their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Citigroup assumed coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target for the company. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a $240.00 price target on shares of Danaher in a research note on Wednesday, July 22nd. Finally, Stifel Nicolaus cut their price objective on shares of Danaher from $260.00 to $220.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.